ArticlebioRxiv : the preprint server for biology2026
Taccalonolide AJ uncouples tubulin GTP hydrolysis from microtubule depolymerization.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Microtubules are dynamic polymers of tubulin subunits that are vital for a variety of eukaryotic cell functions, including intracellular trafficking and cell division. Microtubule-targeting drugs are among the oldest and most widely used chemotherapeutics. Despite their extensive use, the development and optimization of these drugs is hindered by our limited understanding of the molecular impacts on microtubules. Recent high-resolution structures have begun to explain how paclitaxel (Taxol) stabilizes microtubules: it reverses the hydrolysis-driven lateral strain at the microtubule seam and induces an expanded, GTP-like conformational state that promotes polymerization. In this work, we demonstrate that the microtubule-targeting natural product taccalonolide AJ (taccaAJ) stabilizes microtubules in a manner completely distinct from paclitaxel. Using cryo-EM, we show that taccaAJ stabilizes a compacted, post-GTP hydrolysis state, which is usually prone to depolymerization.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.